Minerva Neurosciences, Inc. (NERV) Return on equity 2017–2021
Minerva Neurosciences, Inc. (NERV) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-625.7%FY2021 · since FY2017: -24.0% → -625.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -625.7% | -629.4 pp |
| FY2020 | 3.7% | +263.5 pp |
| FY2019 | -259.8% | -204.3 pp |
| FY2018 | -55.6% | -31.6 pp |
| FY2017 | -24.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice